Astrazeneca Pharma Polandsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-06-13
Share capital
2 000 000,00 PLN
Activity description

Astrazeneca Pharma Poland is a biopharmaceutical company that develops and manufactures medicines for major challenges in modern medicine. Its therapeutic areas include oncology, cardiovascular and metabolic diseases, respiratory diseases, autoimmune conditions, neurological diseases, infectious diseases and vaccines.

Registered address
ul. Postępu 14, 02-676 Warszawa, Poland
Website
astrazeneca.plWebsite active
Social media
Electronic delivery address
AE:PL-82425-23103-THBTS-19

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 466.14mMedianUSD 72.15kAverageUSD 3.22m
Net profit
This companyUSD 53.48mMedianUSD 87.69AverageUSD 112.20k
Operating costs
This companyUSD 423.22mMedianUSD 75.02kAverageUSD 3.02m
Assets
This companyUSD 338.63mMedianUSD 121.49kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2003-10-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
Aid for research and development projects: experimental development
$1.7M

Tenders

4 tenders recorded as contractor, with a total value of $7,497,699.

SubjectAmount
Przetarg uzupełniający na dostawę do WCSKJ produktów leczniczych stosowanych w programach lekowych i chemioterapii
—
Zakup wraz z dostawą leków ogólnoszpitalnych dla Samodzielnego Publicznego Zakładu Opieki Zdrowotnej w Puławach, z podziałem na 83 części.
$3.4M
Dostawa produktów leczniczych z programów lekowych oraz nowych produktów leczniczych
$3.4M

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Barbara Elżbieta Kozierkiewicz — Vice President of the Management Board
Edyta Wojtkiewicz — Management Board Member
Marta Paulina Jagnieża — Vice President of the Management Board
Wiktor Jerzy Janicki — President of the Management Board

Manner of representation

Each of the members of the management board is authorized to make declarations and sign documents on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Astrazeneca Continent B.v.
99$13,371.152.475%
Others
3,901$526,877.3697.525%

Beneficial owners

Person
Marta Jagnieza (48)
Wiktor Jerzy Janicki (49)
Barbara Kozierkiewicz (55)
Edyta Wojtkiewicz (52)

Change history

DateEvent
2015-12-29Address change
2007-01-02Address change
2003-11-25Share capital change
2003-10-09Address change
2002-08-19Address change

FAQ

Last updated: 2026-07-12